NCT01721668

Brief Summary

Improving arm and hand function after stroke has been difficult to achieve within the rehabilitation service provided in the acute stage often due to the limited resource in health care. While spontaneous recovery plateaus after 6 months, the prolonged disability affects quality of life and social participation in stroke survivors. This study is aimed at improving chronic motor impairment arm and hand impairment by providing the intervention with intensive training schedule. This study will compare two types of rehabilitation intervention using a randomized controlled trial. Measurements also will be taken on various brain functions non-invasively to help discover how each of the intervention strategies works differently to repair the brain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Nov 2012

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2012

Completed
Same day until next milestone

Study Start

First participant enrolled

November 1, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 6, 2012

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

August 5, 2016

Status Verified

August 1, 2016

Enrollment Period

3.3 years

First QC Date

November 1, 2012

Last Update Submit

August 3, 2016

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in performance on Action Research Arm Test

    Changes in performance from baseline to post-intervention at 5 weeks, to post-intervention at 10 weeks, and to follow-up at 4 mos will be measured.

    Baseline, post-5-weeks, post-10-weeks, and 4-month-follow-up

  • Change in performance on Chedoke Arm and Hand Inventory

    Changes in performance from baseline to post-intervention at 5 weeks, to post-intervention at 10 weeks, and to follow-up at 4 mos will be measured.

    Baseline, post-5-weeks, post-10-weeks, and 4-month-follow-up

  • Change in status on Stroke Impact Scale

    Changes in performance from baseline to post-intervention at 5 weeks, to post-intervention at 10 weeks, and to follow-up at 4 mos will be measured.

    Baseline, post-5-weeks, post-10-weeks, and 4-month-follow-up

Secondary Outcomes (2)

  • Brain structure

    Pre, post-5-weeks, post-10-weeks, and 4-month-follow-up

  • Brain Function

    Baseline, post-5-weeks, post-10-weeks, and 4-month-follow-up

Study Arms (2)

MSR - Music Supported Rehabilitation

EXPERIMENTAL

Behavioral: Music Supported Rehabilitation

Behavioral: Music Supported Rehabilitation

CU/ET

ACTIVE COMPARATOR

Experimental: CU/ET (Conventional Upper Extremity Therapy)

Behavioral: Conventional Upper Extremity Therapy

Interventions

Music Supported Rehabilitation -using musical exercises to improve hand and arm motor functioning.

MSR - Music Supported Rehabilitation

-GRASP (Graded Repetitive Arm Supplementary Program-developed Janice Eng, PhD, PT/OT Jocelyn Harris, PhD, OT, Andrew Dawson, MD, FRCP, Bill Miller, PhD, OT) protocol will be used to improve arm and hand function in people living with stroke.

CU/ET

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • post-acute stroke patients with unilateral first-time MCA stroke sustained . (more than 6 months ago prior to the enrolment to the study).
  • Patients' residual motor impairments in the affected hand and arm should be greater than stage 3 on the Chedoke McMaster scale.

You may not qualify if:

  • Patients with moderate apraxia, aphasia or dementia, and patients with severe sensory loss in the paretic hand, severe language-communication disability, posture problems, involuntary movements, high-blood pressure, depression or other psychological disorders, metal in body that interferes with MEG and MRI measurements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baycrest Centre for Geriatric Care

Toronto, Ontario, M6A2E1, Canada

Location

MeSH Terms

Conditions

StrokeParesis

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Deirdre R Dawson, PhD

    Baycrest

    PRINCIPAL INVESTIGATOR
  • Bernhard Ross, PhD

    Baycrest

    PRINCIPAL INVESTIGATOR
  • Takako Fujioka, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Deirdre Dawson, Senior Scientist Rotman Research Institute

Study Record Dates

First Submitted

November 1, 2012

First Posted

November 6, 2012

Study Start

November 1, 2012

Primary Completion

March 1, 2016

Study Completion

March 1, 2016

Last Updated

August 5, 2016

Record last verified: 2016-08

Locations